CTHIn ForceLegislation
National Health (Botulinum Toxin Program) Special Arrangement 2025
14Rates of payment for approved hospital authorities for private hospitals
Start here
Get a plain-English read of 14
Turn the raw legal text into a practical explanation grounded in National Health (Botulinum Toxin Program) Special Arrangement 2025.
#### 14 Rates of payment for approved hospital authorities for private hospitals
(1) For the purposes of subsection 99(4) of the Act, the amount payable to an approved hospital authority for a private hospital in respect of a special arrangement supply of a botulinum toxin pharmaceutical benefit by the authority is the amount, if any, by which the dispensed price for the supply of the benefit exceeds the amount that the authority was entitled to charge under section 87 of the Act in respect of the supply.
> Note 1: Section 87 of the Act limits the amounts that approved hospital authorities can charge patients for the supply of pharmaceutical benefits.
> Note 2: However, see Part 4 of this instrument in relation to the supply of a pharmaceutical benefit to a CTG registered patient.
(2) This section applies despite the National Health (Commonwealth Price ‑ Pharmaceutical benefits supplied by private hospitals) Determination 2020 (PB 99 of 2020).
> Note: See subsection 99(4) of the Act (read with section 10 of this instrument) for the entitlement of an approved hospital authority to payment for the supply of pharmaceutical benefits to patients receiving treatment in, at or from a hospital in respect of which the authority is approved.